We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-7.31%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.4% |
| 2 | Technology | 12.96% |
| 3 | Financials | 11.29% |
| 4 | Healthcare | 10.46% |
| 5 | Consumer Discretionary | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Republic Services
RSG
$67.4B
| $94.9K | 0.03% |
1,157
-310
| -21% | -$25K |
|
302
Tilray
TLRY
$549M
| $93.1K | 0.02% |
1,307
+191
| +17% | +$15.4K |
|
|
TCDA
303
DELISTED
Tricida, Inc. Common Stock
TCDA
| $92.9K | 0.02% |
3,380
| – | – |
|
|
CCXI
304
DELISTED
ChemoCentryx, Inc.
CCXI
| $92.7K | 0.02% |
1,612
-517
| -24% | -$28.1K |
|
305
United Parcel Service
UPS
$83.7B
| $92.5K | 0.02% |
832
-1,954
| -70% | -$195K |
|
306
Phathom Pharmaceuticals
PHAT
$624M
| $91.4K | 0.02% |
2,777
-325
| -10% | -$12.5K |
|
307
Philip Morris
PM
$299B
| $90.9K | 0.02% |
1,298
-20,348
| -94% | -$1.48M |
|
|
BCEL
308
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $90.9K | 0.02% |
4,270
| – | – |
|
309
BioMarin Pharmaceuticals
BMRN
$12.5B
| $89.8K | 0.02% |
728
| – | – |
|
310
Freeport-McMoran
FCX
$98.4B
| $89.7K | 0.02% |
7,756
-8,081
| -51% | -$74.1K |
|
311
Under Armour
UAA
$2.15B
| $86.9K | 0.02% |
8,922
-63,734
| -88% | -$605K |
|
|
ATRS
312
DELISTED
Antares Pharma, Inc.
ATRS
| $86.6K | 0.02% |
31,494
-317
| -1% | -$884 |
|
313
PTC Therapeutics
PTCT
$5.6B
| $85.8K | 0.02% |
1,691
| – | – |
|
314
State Street Financial Select Sector SPDR ETF
XLF
$53.2B
| $85.2K | 0.02% |
3,682
-1,303
| -26% | -$29.6K |
|
315
ADMA Biologics
ADMA
$2B
| $83.7K | 0.02% |
+28,553
| New | +$82K |
|
316
CALL
Logitech
LOGI
$14.2B
| $82.7K | 0.02% |
124
+114
| +1,140% | +$6.07K |
|
317
Valero Energy
VLO
$117B
| $80K | 0.02% |
1,360
-38,231
| -97% | -$2.28M |
|
318
Autodesk
ADSK
$45.9B
| $78.2K | 0.02% |
327
-79
| -19% | -$15.5K |
|
319
Texas Instruments
TXN
$237B
| $77.6K | 0.02% |
611
-500
| -45% | -$58.3K |
|
320
NetEase
NTES
$75.4B
| $77.3K | 0.02% |
900
| – | – |
|
321
Xcel Energy
XEL
$45.3B
| $76.7K | 0.02% |
1,227
-1,249
| -50% | -$78.7K |
|
322
Cardinal Health
CAH
$54.1B
| $75.9K | 0.02% |
1,454
-46,590
| -97% | -$2.4M |
|
|
NBRV
323
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $74.3K | 0.02% |
440
+112
| +34% | +$18.7K |
|
324
Chemed
CHE
$6.67B
| $74K | 0.02% |
164
| – | – |
|
|
ANSS
325
DELISTED
Ansys
ANSS
| $72.9K | 0.02% |
250
| – | – |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.4M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.